Alnylam Pharmaceuticals IncNarrowed quarterly guidance and reduced full-year product revenue target
US stock futures pointed higher Friday morning, with E-mini S&P 500 contracts up about 0.3% and Nasdaq-100 futures ahead roughly 0.5%, as investors awaited the June US PCE price index. The headline PCE is expected to dip 0.1% month on month, while the core reading is seen up 0.2%, suggesting inflation is easing slowly but remains above the Federal Reserve's 2% target. Second quarter US GDP is projected at 2.1% annualised, supported by consumer spending and AI-related investment. Among top movers, Nebius Group surged 27.13% ahead of its Q2 2026 earnings release, Bloom Energy jumped 26.49% after analyst updates and raised 2026 revenue guidance, and Sandisk gained 25.99%. On the losing side, Alnylam Pharmaceuticals fell 28.31% after narrowing quarterly guidance and reducing its full-year product revenue target, Fair Isaac declined 17.01% following Q3 results and a sharply lower price target from RBC, and Tradeweb Markets dropped 9.60% after its Q2 earnings update.
Alnylam Pharmaceuticals IncNarrowed quarterly guidance and reduced full-year product revenue target
AbbVie Inc
Moderna Inc
Tradeweb Markets IncTradeweb Markets dropped 9.60% after its Q2 earnings update.
Ares Management LP
T. Rowe Price Group Inc
Bloom Energy CorpAnalyst updates and raised 2026 revenue guidance
Exxon Mobil Corp
Fair Isaac CorporationQ3 results and sharply lower price target from RBC
Nebius Group N.V.Surged ahead of Q2 2026 earnings release
Sandisk CorpGained after analyst updates and raised guidance
Church & Dwight Company Inc
Chevron Corp
STERIS plc